For example, previous studies have confirmed that HSP90AA1 is a sensitive biomarker of lung cancer and is valuable in predicting the response of lung cancer patients to surgery or chemotherapy (Shi et al., 2014). This evidence concerns the gene HSP90AA1 and lung carcinoma.